Stakeholders to Scope Out Value in GI Cancer Therapy

Dr John Marshall previews the upcoming 2015 Ruesch Symposium, in which policy makers, insurers, regulators, researchers, and patients debate about what therapies are worth pursuing in GI cancer.

Source: Medscape Oncology - November 30, 2015 Category: Cancer & Oncology Authors: Medscape Source Type: podcasts